Intensity Therapeutics Inc
INTS
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.73M
Close$
$0.87
79.5% downside
Current Fair Value
79.5% downsideOvervalued by 79.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.73 Million |
|---|---|
| Enterprise Value | $-2,410,576.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-8.56 |
| Beta | 3.06 |
| Outstanding Shares | 25,339,180 |
Return
| Return on Equity | -107.16% |
|---|---|
| Return on Assets | -87.00% |
| Return on Invested Capital | -110.50% |
Valuation & Multiples
| P/E Ratio | -0.59 |
|---|---|
| PEG | 2.16 |
| Price to Sales | -4.24 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 92.71 |
| Enterprise Value to EBIT | 0.22 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.04 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 12, 2026
EPS Estimate
$-1.08
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.87
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.56%▼ 20.21% |
|---|---|
| Total Invested | $836,287▼ 47.21% |
| Investors Holding | 13▼ 22.00% |
ESG Score
No data